Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 1000 participants.
Also called NCT01120301
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,000 participants
- Sponsor
- PhotoThera, Inc
- Registry
-
NCT01120301
-
- Other papers using this trial's data
- Transcranial laser therapy in acute stroke treatment: results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- Not reported
- Countries
- United States, Austria, Canada, Finland, France, Germany, Peru, Spain, Sweden, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT01120301. Randomized; quadruple masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2012-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
- Acronym
- NEST-3
- Condition
- Acute Ischemic Stroke
- Intervention (Device)
- NeuroThera® Laser System
- Lead sponsor
- PhotoThera, Inc
Record details
- Record id
cardio:ct-nct01120301- Content hash
fe408b61b8877c4ad249d9ce4df0c9ea97a46f1bf55ffd68cfd7dc17f92fb27e